Clinical Trial Update: Procalcitonin in Diagnosis of Bacterial Infections in Young Infants

View source ↗

Summary

Completed clinical trial evaluating procalcitonin as a diagnostic biomarker for bacterial infections in young infants with suspected sepsis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sepsis

Snippet

Sponsor: Belfast Health and Social Care Trust | Conditions: Sepsis | Status: COMPLETED